Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
       Home    Substance
1 result for Superlist ID equals S900006480
Drug Name: Dorgenmeltucel-L [USAN]
Description: HyperAcute-Melanona (IND #12036) is a live, whole cell immunotherapy product for use in patients diagnosed with melanoma that is produced by NewLink Genetics. The cancer vaccine consists of equal doses of three allogenic human melanoma cancer cell lines (HAM1, HAM2, and HAM3) engineered to express the murine alpha-(1,3)-galaacosyltransferase gene. 

Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Aug 2019